NIKI Niki BioSolutions, Inc.
Measuring & Controlling Devices, NEC · Nasdaq · SEC CIK 1734005 · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (FY2023), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-66.7%
TTM net income YoY71.2%
TTM EPS YoY77.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin2.4%
Operating margin—
Net margin-654.8%
FCF margin-1,791.3%
EBITDA margin—
Returns
ROE-13.9%
ROA-13.6%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets25.5%
Debt / equity0.00x
Current ratio1.18x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.73x
Accruals ratio23.6%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2024Q4*2024-12-31 | 2024Q3*2024-09-30 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | — | — | — | — |
| R&D expense | $91,711 | $241,793 | -$284,466 | $440,704 |
| SG&A expense | $211,717 | $173,920 | $98,823 | $244,476 |
| Net income | -$307,495 | -$613,995 | -$919,900 | -$704,110 |
| EPS (diluted) | — | — | — | — |
| Balance sheet | ||||
| Cash & equivalents | $3.45M | $2.27M | $874,238 | $754,592 |
| Current assets | $3.59M | $2.48M | $959,554 | — |
| Total assets | $18.69M | $17.58M | $16.13M | — |
| Current liabilities | $4.59M | $4.42M | $4.34M | — |
| Total liabilities | $4.90M | $4.42M | $4.35M | — |
| Shareholders' equity | $23.12M | $22.53M | $21.13M | $12.51M |
| Cash flow statement | ||||
| Operating cash flow | -$535,719 | -$484,283 | $119,646 | -$28,493 |
| Investing cash flow | — | — | $0 | $0 |
| Financing cash flow | $1.72M | $0 | — | — |
| Depreciation & amortization | — | — | $19,219 | -$19,219 |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.